Sector Gamma AS’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-506,077
Closed -$8.1M 33
2018
Q2
$8.1M Sell
506,077
-832,558
-62% -$12.3M 1.35% 21
2018
Q1
$17.3M Sell
1,338,635
-80,497
-6% -$1M 3.12% 14
2017
Q4
$17.8M Sell
1,419,132
-759,920
-35% -$9.93M 2.99% 14
2017
Q3
$28.8M Sell
2,179,052
-9,666
-0.4% -$133K 4.39% 8
2017
Q2
$34.6M Sell
2,188,718
-128,571
-6% -$1.87M 5.03% 8
2017
Q1
$33.1M Sell
2,317,289
-38,089
-2% -$521K 5.27% 8
2016
Q4
$30.2M Buy
2,355,378
+14,484
+0.6% +$183K 5.67% 5
2016
Q3
$27.8M Buy
2,340,894
+228,269
+11% +$2.67M 4.87% 6
2016
Q2
$23.1M Sell
2,112,625
-856,563
-29% -$8.37M 4.39% 9
2016
Q1
$27.2M Buy
2,969,188
+611,729
+26% +$5.05M 5.6% 4
2015
Q4
$22.9M Buy
2,357,459
+176,987
+8% +$1.71M 5.88% 7
2015
Q3
$19M Buy
2,180,472
+505,420
+30% +$4.72M 5.15% 7
2015
Q2
$16.9M Buy
1,675,052
+287,396
+21% +$3.34M 4.32% 10
2015
Q1
$18.6M Buy
1,387,656
+20,298
+1% +$266K 4.92% 6
2014
Q4
$17.5M Buy
1,367,358
+8,239
+0.6% +$94.3K 3.9% 8
2014
Q3
$14.7M Sell
1,359,119
-24,119
-2% -$276K 3.45% 12
2014
Q2
$17.8M Buy
1,383,238
+157,011
+13% +$1.71M 4.2% 7
2014
Q1
$12.7M Buy
1,226,227
+340,290
+38% +$3.83M 3.03% 12
2013
Q4
$8.62M Buy
885,937
+380,886
+75% +$3.42M 2.32% 18
2013
Q3
$5.01M Buy
+505,051
New +$4.95M 1.28% 27

Other funds holding IRWD

Sector Gamma AS's IRWD Position: Q3 2018 in Review

Sector Gamma AS sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2018, closing a stake of 506,077 shares — an estimated $8.1M sold.

Sector Gamma AS first reported a position in IRWD in Q3 2013 and held it in 20 quarters. The position peaked at $34.6M in Q2 2017. 151 funds tracked by Wall St. Rank hold IRWD as of Q3 2018.

  • Sector Gamma AS reported no remaining Ironwood Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Sector Gamma AS sold 506,077 Ironwood Pharmaceuticals shares in Q3 2018, an estimated $8.1M.
  • Sector Gamma AS first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 20 quarters.
  • Sector Gamma AS's Ironwood Pharmaceuticals position peaked at $34.6M in Q2 2017.
  • 151 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2018.

Based on Sector Gamma AS's 13F filing for Q3 2018, filed 8 Nov 2018.